Non-ownership Filings
| Imfinzi improved DFS in early bladder cancer | May. 09, 2025 |
| Enhertu improved pCR in early-stage breast cancer | May. 07, 2025 |
| Calquence combination approved in EU for 1L MCL | May. 06, 2025 |
| Breztri met primary endpoints in Ph3 asthma trials | May. 02, 2025 |
| Total Voting Rights | May. 01, 2025 |
| Fixed-duration Calquence recommended in EU for CLL | Apr. 29, 2025 |
| Update on CAPItello-280 Phase III trial | Apr. 29, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | May. 01, 2025 |
| Holding(s) in Company | Mar. 12, 2025 |
| Director/PDMR Shareholding | Mar. 07, 2025 |
| Director/PDMR Shareholding | Mar. 06, 2025 |
| Director/PDMR Shareholding | Mar. 05, 2025 |
| Holding(s) in Company | Feb. 18, 2025 |
| Director/PDMR Shareholding | Nov. 20, 2024 |